HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BRIEF
July 28, 2003
- PI Study on Ono's Anti-AIDS Drug Started by GSK in US
July 28, 2003
- Dainippon to Assign More Product Managers to Gasmotin, Prorenal
July 28, 2003
- Livact Inhibits Complications of Hepatic Cirrhosis: Ajinomoto
July 28, 2003
- Imigran Nasal Spray 20 Highly Evaluated by Migraine Patients: GSK Survey
July 28, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
July 28, 2003
- Mochida Launches Novel Masticatory Supplementary Health Food
July 28, 2003
- Promotion Measure Boosting Prescription of GEs: EMA Survey
July 28, 2003
- Omron Healthcare Aiming for Sales of \65 Billion in FY2007
July 28, 2003
- Meiji Seika Reorganizing Domestic, Overseas Production to Cut Costs
July 28, 2003
- Council Calls For Sale of Drug with Mild Effects via General Retailers
July 28, 2003
- BUSINESS NEWS IN BRIEF
July 21, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
July 21, 2003
- NEW PRODUCTS NEWS IN BRIEF
July 21, 2003
- Pfizer to Contain Share of Diflucan Generics to 5-10%
July 21, 2003
- Chuikyo Subcommittee Discusses Environment to Promote GE Use
July 21, 2003
- WORLD NEWS IN BRIEF
July 21, 2003
- Gov't to Study Stronger Protection of New Drug Data
July 21, 2003
- Developing New Non-viral
July 21, 2003
- Precautions for 10 Drugs to Be Revised
July 21, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
